Background Disulfidptosis and the disulfidptosis-related gene SLC7A11 have recently
attracted significant attention for their role in tumorigenesis and tumour management …

Diffuse Large B-cell Lymphoma (DLBCL), with its intrinsic genetic and epigenetic
heterogeneity, exhibits significantly variable clinical outcomes among patients treated with …

Pancreatic cancer stands as one of the most lethal malignancies, characterized by delayed
diagnosis, high mortality rates, limited treatment efficacy, and poor prognosis. Disulfidptosis …

Background As the most common primary bone cancer, the therapy of osteosarcoma
requires further study. An anthraquinone derivative, emodin, has been found to have …

Introduction Human constitution is closely linked to health and disease and serves as a
basis for disease diagnosis. In this work, the urinary metabolomics of three basic traditional …

Background Stomach adenocarcinoma (STAD), a frequently occurring gastrointestinal
tumour, is often detected late and has a poor prognosis. Long non-coding RNAs (lncRNAs) …

Background Bexarotene, also recognized as Targretin, is categorized as a retinoid, a type of
cancer drug. Nevertheless, the precise mechanisms of Bexarotene in relation to colon …

Background The study of molecular markers for diagnosis and prognosis is of great clinical
significance for HNSCC patients. In this study, we proposed that FSCN1 has a potential …

Background: As the most invasive breast cancer (BrCa), triple-negative BrCa (TNBC) has
the worst survival. The use of dexmedetomidine potentially affected BrCa surgery and …

This study introduces a novel prognostic model for glioma outcomes based on disulfidptosis,
a unique programmed cell death pathway, highlighting its potential in cancer progression …